AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events

AGORA PRS Seminar | May 6th
Events
Lausanne Proteomics Day 2025 | May 7th
Events

You are invited: AGORA Apéro | May 8th
Events
Oncology Grand Rounds, Dr. Philippe Ivanyi | May 8th
Events
ISREC Foundation Research Seminar, Prof. Gert Attard | May 19th
Events
ISREC Foundation Research Seminar, Prof. Nir Friedman | May 20th
Events
🌱 2nd AGORA Sustainability Day | May 21st
Events

AGORA Tumor Microenvironment Journal Club
Latest publications
Average Dose Rate is the Major Temporal Beam Structure Parameter for Preserving Murine Intestines with Pulsed Electron FLASH-RT.
Grilj V, Zayas AV, Sesink A, (…), Bochud F, Bourhis J, Herrera FG
Int J Radiat Oncol Biol Phys – 2025 May 2
HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine.
Lecointre M, Guillot J, Marcone R, (…), Fournier N, Homicsko K, Hanahan D
Cancer discovery – 2025 Apr 27
Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.
Oh J, Hoelzl J, Carlson JCT, (…), Pittet MJ, Pai SI, Weissleder R
Cell reports. Medicine – 2025 Apr 25
Tumor-Infiltrating Clonal Hematopoiesis.
Pich O, Bernard E, Zagorulya M, (…), Bonnet D, Papaemmanuil E, Swanton C
The New England journal of medicine – 2025 Apr 24
Reprogramming the tumor immune microenvironment to treat glioblastoma.
Joyce JA
Nature Medicine – 2025 Apr 15